Effect of cyclosporin A on inflammatory cytokine production by human alveolar macrophages

Respiratory Medicine

Volumn 92, Issue 5, 1998, Pages 722-728

  Losa Garcia, J E ^a   Mateos Rodriguez F ^a   Jimenez Lopez A ^a   Garcia Salgado, M J ^a   Martin De Cabo M R ^a   Ferez Losada, J ^a   Perez Arellano J L ^b,c  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^c HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; PRIORITY JOURNAL;

EID: 0031840626     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(98)90002-6     Document Type: Article

References (29)

1. Fathman CG, Myers BD. Cyclosporine therapy for autoimmune disease. N Engl J Med 1992; 326: 1693-1695.
2. Hess AD, Colombani PM, Esa AH. Cyclosporine and the immune response: basic aspects. Crit Rev Immunol 1986; 6: 123-149.
3. Ren K, Van Liew JB, Noble B. The effect of cyclosporin A on disease progression in proliferative immune complex glomerulonephritis. Clin Immunol Immunopathol 1993; 66: 107-113.
4. Alton EWFM, Johnson M, Turner-Warwick M. Advanced cryptogenic fibrosing alveolitis: preliminary report on treatment with cyclosporin A. Respir Med 1989; 83: 277-279.
5. Fukazawa M, Kawano M, Hisano S et al. Efficacy of cyclosporin A for idiopathic pulmonary fibrosis. Eur J Pediatr 1990; 149: 441-442.
6. Moolman JA, Bardin PG, Rossouw DJ et al. Cyclosporin as a treatment for interstitial lung disease of unknown aetiology. Thorax 1991; 46: 592-595.
7. Venuta F, Rendina EA, Ciriaco P et al. Efficacy of Cyclosporine to reduce steroids in patients with idiopathic pulmonary fibrosis before lung transplantation. J Heart Lung Transplant 1993; 12: 909-914.
8. Rebuck AS, Stiller CR, Braude AC et al. Cyclosporin for pulmonary sarcoidosis. Lancet 1984; 1: 174.
9. Lynch JP III, Standiford TJ, Rolfe MW et al. Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8. Am Rev Respir Dis 1992; 145: 1433-1439.
10. Moore SA, Stricter RM, Rolfe MW et al. Expression and regulation of human alveolar macrophage-derived interleukin-1 receptor antagonist. Am J Respir Cell Mol Biol 1992; 6: 569-575.
11. Thomassen MJ, Meeker DP, Antal JM et al. Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages. Am J Respir Cell Mol Biol 1992; 7: 257-260.
12. Kelley J. Cytokines of the lung. Am Rev Respir Dis 1990; 141: 765-788.
13. Rolfe MW, Kunkel SL, Rowens B et al. Suppression of human alveolar macrophage-derived cytokines by amiloride. Am J Respir Cell Mol Biol 1992; 6: 576-582.
14. Herzyk DJ, Allen JN, Marsh CB et al. Macrophage and monocyte I L-1 beta regulation differs at multiple sites. Messenger RNA expression, translation, and post-translational processing. / Immunol 1992; 149: 3052-3058.
15. Manca F, Kunkl A, Celada F. Inhibition of the accessory function of murine macrophages in vitro by Cyclosporine. Transplantation 1985; 39: 644-649.
16. Reisman L, Cooper D, Lieberman KV et al. Cyclosporine suppresses IE-1 production by isolated human monocytes and by the human histiocytoma cell line, THP-1. Transplant Proc 1990; 22: 1744-1746.
17. Tipton DA, Pabst MJ, Dabbous MK. Interleukin-1 beta- and tumor necrosis factor-alpha-independent monocyte stimulation of fibroblast collagenase activity. J Cell Biochem 1990; 44: 253-264.
18. Andersson J, Nagy S, Groth CG et al. Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. Immunology 1992; 75: 136-142.
19. Pigatto PD, Pigatto LB, Bigardi A et al. Factors secreted by untreated psoriatic monocytes enhance neutrophil functions. J Invest Dermatol 1990; 94: 372-376.
20. Moutabarrik A, Takahara S, Namiki M et al. Effect of FK 506 and cyclosporine on the expression of IL-6 and its receptor on stimulated monocytes. Transplant Proc 1993; 25: 2320-2321.
21. Southcott AM, Jones KP, Li D et al. Interleukin 8. Differential expression in lone fibrosing alveolitis and systemic sclerosis. Am J Respir Crit Care Med 1995; 151: 1604-1612.
22. Nakamura H, Fujishima S, Waki Y et al. Priming of alveolar macrophages for interleukin-8 production in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995; 152: 1579-1586.
23. Martinet Y, Pinkston S, Saltini C et al. Evaluation of the in vitro and in vivo effects of cyclosporine on the lung T-lymphocyte alveolitis of active pulmonary sarcoidosis. Am Rev Respir Dis 1988; 138: 1242-1248.
24. Hunninghake GW, Kalika AR. Approaches to the treatment of pulmonary fibrosis. Am J Respir Crit Care Med 1995; 151:915-918.
25. Chapman I, Mazzoni L. Mechanisms of inhibition by cyclosporin A on pulmonary leukocyte accumulation. Trends Pharmacol Sci 1994; 15: 99-101.
26. Goldstein RH, Fine A. Potential therapeutic initiatives for fibrogenic lung diseases. Chest 1995; 108: 848-855.
27. O'Riordan TG, Lacono A, Keenan RJ et al. Delivery and distribution of aerosolized cyclosporine in lung allograft recipients. Am J Respir Crit Care Med 1995; 151: 516-521.
28. Lacono AT, Keenan RJ, Duncan SR et al. Aerosolized cyclosporine in lung recipients with refractory chronic rejection. Am J Respir Crit Care Med 1996; 153: 1451-1455.
29. Keenan RJ, Zeevi A, Lacono AT et al. Efficacy of inhaled cyclosporine in lung transplant recipients with refractory rejection: correlation of intragraft cytokine gene expression with pulmonary function and histologie characteristics. Surgery 1995; 118: 385-391.